Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023
   PCE(x) 51.24-970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is 51.24 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202551.24
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 51.24
Positive
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹76.4 Cr -0.7% -8.1% -64.6% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,841.0 Cr 0.7% -2.7% -10% Stock Analytics
KIRI INDUSTRIES ₹3,364.0 Cr -9% 6.3% -7.3% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,633.7 Cr 1.2% -0.4% -37.6% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,237.9 Cr -6.1% -7.2% 11% Stock Analytics
BODAL CHEMICALS ₹660.1 Cr 0% -11.2% -32.6% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-0.7%

-8.1%

-64.6%

SENSEX

-0.5%

1%

4.6%


You may also like the below Video Courses